Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Corvus Pharmaceuticals, Inc. (CRVS) had Return on Investments of -5.69% for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-13.69M |
|
-- |
|
-- |
|
$14.88M |
|
$-14.88M |
|
$1.19M |
|
$-13.69M |
|
$-13.69M |
|
$-13.69M |
|
$-13.69M |
|
$-13.69M |
|
$-13.69M |
|
$-14.88M |
|
$-14.87M |
|
90.00M |
|
90.00M |
|
$-0.15 |
|
$-0.15 |
|
| Balance Sheet Financials | |
$239.95M |
|
$0.28M |
|
$13.25M |
|
$253.19M |
|
$12.11M |
|
-- |
|
$0.41M |
|
$12.52M |
|
$240.68M |
|
$240.68M |
|
$240.68M |
|
84.09M |
|
| Cash Flow Statement Financials | |
$-10.37M |
|
$-144.85M |
|
$190.75M |
|
$4.58M |
|
$40.10M |
|
$35.53M |
|
$2.65M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
19.81 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-10.46M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-5.69% |
|
-5.69% |
|
-5.41% |
|
|
Return on Investments |
-5.69% |
$2.86 |
|
$-0.12 |
|
$-0.12 |
|